David Thompson
Keine laufenden Positionen mehr
Profil
David E.
Thompson served as Vice President of Corporate Business Development at Eli Lilly & Co. for 34 years until 2005.
He was President & CEO of IVAC Corp.
and a Venture Partner at VantagePoint Management, Inc. He also served as a Director at BrainCells, Inc. and as an Independent Director at Anthera Pharmaceuticals, Inc. Thompson was a Director at Bayhill Therapeutics, Inc. from 2010 to 2013.
He earned his undergraduate degree and MBA from Michigan State University.
Ehemalige bekannte Positionen von David Thompson
Unternehmen | Position | Ende |
---|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Chairman | 17.05.2010 |
VantagePoint Management, Inc.
VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Private Equity Investor | 31.03.2008 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2005 |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Director/Board Member | - |
IVAC Corp.
IVAC Corp. Medical SpecialtiesHealth Technology Part of River Acquisition Corp., IVAC Corp. is a private company that manufactures electronic medical equipment. The company is based in San Diego, CA. IVAC was acquired by River Acquisition Corp. from Eli Lilly & Co. on November 29, 1994. | President | - |
Ausbildung von David Thompson
Michigan State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology BrainCells Inc. discovers and develops drugs. The company was founded by Fred H. Gage and Harry F. Hixson, Jr. in 2003 and is headquartered in San Diego, CA. | Health Technology |
IVAC Corp.
IVAC Corp. Medical SpecialtiesHealth Technology Part of River Acquisition Corp., IVAC Corp. is a private company that manufactures electronic medical equipment. The company is based in San Diego, CA. IVAC was acquired by River Acquisition Corp. from Eli Lilly & Co. on November 29, 1994. | Health Technology |
VantagePoint Management, Inc.
VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Finance |